Journal of Hepatology

1

Suppressor of cytokine signaling expression with increasing severity of murine hepatic ischemia-reperfusion injury

Lorrie A. Langdale, Vicki Hoagland, Whitney Benz, Kimberly J. Riehle, Jean S. Campbell, Denny H. Liggitt, Nelson Fausto

Journal:

Année:

2008

Langue:

english

Fichier:

PDF, 1006 KB

english, 2008

2

Hepatic expression of A Disintegrin And Metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases

Lutz Schwettmann, Michael Wehmeier, Dunja Jokovic, Krasimira Aleksandrova, Korbinian Brand, Michael P. Manns, Ralf Lichtinghagen, Matthias J. Bahr

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 149 KB

english, 2008

3

Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: A pilot clinical study

Riccardo Lencioni, Laura Crocetti, Pasquale Petruzzi, Claudio Vignali, Elena Bozzi, Clotilde Della Pina, Irene Bargellini, Dania Cioni, Filippo Oliveri, Paolo De Simone, Carlo Bartolozzi, Maurizia Bru

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 426 KB

english, 2008

4

Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma

Ryuhei Nishino, Masao Honda, Taro Yamashita, Hajime Takatori, Hiroshi Minato, Yoh Zen, Motoko Sasaki, Hiroyuki Takamura, Katsuhisa Horimoto, Tetsuo Ohta, Yasuni Nakanuma, Shuichi Kaneko

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 825 KB

english, 2008

5

Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients

Eric Lawitz, Maribel Rodriguez-Torres, Andrew J. Muir, Tara L. Kieffer, Lindsay McNair, Ariya Khunvichai, John G. McHutchison

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 594 KB

english, 2008

6

Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas

Massimo Libra, Annunziata Gloghini, Grazia Malaponte, Pietro Gangemi, Valli De Re, Bruno Cacopardo, Demetrios A. Spandidos, Ferdinando Nicoletti, Franca Stivala, Anna Linda Zignego, Antonino Carbone

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 684 KB

english, 2008

7

Pioglitazone in chronic hepatitis C not responding to pegylated interferon-α and ribavirin

Kathrin Overbeck, Daniel Genné, Alain Golay, Francesco Negro

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 102 KB

english, 2008

8

Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C

Xiaowen Su, Leland J. Yee, KyungAh Im, Shannon L. Rhodes, YongMing Tang, Xiaomei Tong, Charles Howell, Darmendra Ramcharran, Hugo R. Rosen, Milton W. Taylor, T. Jake Liang, Huiying Yang

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 143 KB

english, 2008

9

Impact of viral eradication on mortality related to hepatitis C: A modeling approach in France

Sylvie Deuffic-Burban, Pierre Deltenre, Alexandre Louvet, Valérie Canva, Sebastien Dharancy, Antoine Hollebecque, Jeanne Boitard, Jean Henrion, Yazdan Yazdanpanah, Philippe Mathurin

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 179 KB

english, 2008

10

Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC

Hidenori Toyoda, Takashi Kumada, Yuji Kaneoka, Yukio Osaki, Toru Kimura, Akira Arimoto, Hiroko Oka, Osamu Yamazaki, Takao Manabe, Fumihiro Urano, Hobyung Chung, Masatoshi Kudo, Takashi Matsunaga

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 162 KB

english, 2008

11

Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats

Vasilica Matei, Aina Rodríguez-Vilarrupla, Ramon Deulofeu, Héctor García-Calderó, Mercedes Fernández, Jaime Bosch, Joan-Carles Garcia-Pagán

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 322 KB

english, 2008

12

Activation of focal adhesion kinase and JNK contributes to the extracellular matrix and cAMP-GEF mediated survival from bile acid induced apoptosis in rat hepatocytes

Paul Usechak, Anna Gates, Cynthia RL Webster

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 318 KB

english, 2008

13

The influence of alcohol consumption and hepatitis B and C infections on the risk of liver cancer in Europe

Josepa Ribes, Ramon Clèries, Laura Esteban, Víctor Moreno, F. Xavier Bosch

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 776 KB

english, 2008

14

Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids

Byoung-Joon Song, Kwan-Hoon Moon, Nils U. Olsson, Norman Salem Jr.

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 1.06 MB

english, 2008

15

Tumor-specific marker genes for intrahepatic cholangiocarcinoma: Utility and mechanistic insight

Boris Blechacz, Gregory J. Gores

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 77 KB

english, 2008

16

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin

Marina Berenguer

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 204 KB

english, 2008

17

Liver and heart: A new link?

Stefano Bellentani, Giorgio Bedogni, Claudio Tiribelli

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 1.43 MB

english, 2008

18

Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients

Stefan Zeuzem

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 83 KB

english, 2008

19

Herbalife nutritional products and liver injury revisited

Louis Ignarro, David Heber, Y. Steven Henig, Ezra Bejar

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 1.45 MB

english, 2008

20

More reports of potential hepatotoxicity of Herbalife products: Reply

Daniel Shouval, Eran Elinav

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 1.44 MB

english, 2008

21

Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs

Roberto Burioni, Mario Perotti, Nicasio Mancini, Massimo Clementi

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 1.44 MB

english, 2008

22

Compare trial: Updated data

Marcelo O. Silva

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 1.48 MB

english, 2008

23

Herbalife revisited: Reply

Daniel Shouval, Eran Elinav

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 1.43 MB

english, 2008

24

Editorial Board

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 1.37 MB

english, 2008

25

Many Ways One Aim

Journal:

Journal of Hepatology

Année:

2008

Fichier:

PDF, 740 KB

2008

26

44th Annual Meeting of EASL, Copenhagen, Denmark, April 22-26, 2009

Journal:

Journal of Hepatology

Année:

2008

Fichier:

PDF, 5.49 MB

2008

27

2007/2008 e-Series

Journal:

Journal of Hepatology

Année:

2008

Fichier:

PDF, 505 KB

2008

28

Announcements

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 1.38 MB

english, 2008

30

Spanish reports of hepatotoxicity associated with Herbalife® products

Gloria Manso, Laureano López-Rivas, José María Duque, Esther Salgueiro

Journal:

Journal of Hepatology

Année:

2008

Langue:

english

Fichier:

PDF, 1.44 MB

english, 2008

Volume 49; Issue 2

Suppressor of cytokine signaling expression with increasing severity of murine hepatic ischemia-reperfusion injury

Hepatic expression of A Disintegrin And Metalloproteinase (ADAM) and ADAMs with thrombospondin motives (ADAM-TS) enzymes in patients with chronic liver diseases

Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: A pilot clinical study

Identification of novel candidate tumour marker genes for intrahepatic cholangiocarcinoma

Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients

Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas

Pioglitazone in chronic hepatitis C not responding to pegylated interferon-α and ribavirin

Association of single nucleotide polymorphisms in interferon signaling pathway genes and interferon-stimulated genes with the response to interferon therapy for chronic hepatitis C

Impact of viral eradication on mortality related to hepatitis C: A modeling approach in France

Prognostic value of pretreatment levels of tumor markers for hepatocellular carcinoma on survival after curative treatment of patients with HCC

Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats

Activation of focal adhesion kinase and JNK contributes to the extracellular matrix and cAMP-GEF mediated survival from bile acid induced apoptosis in rat hepatocytes

The influence of alcohol consumption and hepatitis B and C infections on the risk of liver cancer in Europe

Prevention of alcoholic fatty liver and mitochondrial dysfunction in the rat by long-chain polyunsaturated fatty acids

Tumor-specific marker genes for intrahepatic cholangiocarcinoma: Utility and mechanistic insight

Systematic review of the treatment of established recurrent hepatitis C with pegylated interferon in combination with ribavirin

Liver and heart: A new link?

Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients

Herbalife nutritional products and liver injury revisited

More reports of potential hepatotoxicity of Herbalife products: Reply

Perspectives for the utilization of neutralizing human monoclonal antibodies as anti-HCV drugs

Compare trial: Updated data

Herbalife revisited: Reply

Editorial Board

Many Ways One Aim

44th Annual Meeting of EASL, Copenhagen, Denmark, April 22-26, 2009

2007/2008 e-Series

Contents

Announcements

Spanish reports of hepatotoxicity associated with Herbalife® products